sclerotiorin has been researched along with Neoplasms* in 1 studies
1 other study(ies) available for sclerotiorin and Neoplasms
| Article | Year |
|---|---|
Preparation, COX-2 Inhibition and Anticancer Activity of Sclerotiorin Derivatives.
The latest research has indicated that anti-tumor agents with COX-2 inhibitory activity may benefit their anti-tumor efficiency. A series of sclerotiorin derivatives have been synthesized and screened for their cytotoxic activity against human lung cancer cells A549, breast cancer cells MDA-MB-435 using the MTT method. Among them, compounds Topics: A549 Cells; Antineoplastic Agents; Benzopyrans; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2020 |